554
Participants
Start Date
September 18, 2020
Primary Completion Date
September 10, 2021
Study Completion Date
September 10, 2021
HCV screening
All patients will have HCV screening using rapid tests. HIV and HBV testing will also be conducted and patients will be appropriately referred to appropriate health services.
Diagnosis of hepatitis C
HCV-RNA assay (GeneXpert, Cepheid) will be performed for all participants with positive HCV serology to determine if patients have chronic hepatitis C (defined by HCV-RNA\>10 UI/mL). In addition a measure of the liver stiffness will be performed.
HCV treatment
Direct-Acting Antiviral drugs will be prescribed for 8 or 12 weeks according to liver assessment.
CHU Montpellier, Montpellier
ANRS, Emerging Infectious Diseases
OTHER_GOV